<code id='FEEF2E6F5F'></code><style id='FEEF2E6F5F'></style>
    • <acronym id='FEEF2E6F5F'></acronym>
      <center id='FEEF2E6F5F'><center id='FEEF2E6F5F'><tfoot id='FEEF2E6F5F'></tfoot></center><abbr id='FEEF2E6F5F'><dir id='FEEF2E6F5F'><tfoot id='FEEF2E6F5F'></tfoot><noframes id='FEEF2E6F5F'>

    • <optgroup id='FEEF2E6F5F'><strike id='FEEF2E6F5F'><sup id='FEEF2E6F5F'></sup></strike><code id='FEEF2E6F5F'></code></optgroup>
        1. <b id='FEEF2E6F5F'><label id='FEEF2E6F5F'><select id='FEEF2E6F5F'><dt id='FEEF2E6F5F'><span id='FEEF2E6F5F'></span></dt></select></label></b><u id='FEEF2E6F5F'></u>
          <i id='FEEF2E6F5F'><strike id='FEEF2E6F5F'><tt id='FEEF2E6F5F'><pre id='FEEF2E6F5F'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:5
          STAT

          What if CRISPR isn’t all that commercial? How does the NurOwn story end? And how do you pronounce “Bayer”?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Live from Boston at the 2023 STAT Summit, we discuss the latest news in the life sciences, including a milestone in genome editing, a twist in the search for ALS treatments, and the polarizing process of saying words in biotech.

          advertisement

          For more on what we cover, here’s the latest from the Summit; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          focus

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          A Q&A with the global head of Boehringer Ingelheim's innovation unit
          A Q&A with the global head of Boehringer Ingelheim's innovation unit

          MichelPairetCourtesyBoehringerIngelheimLONDON—Ataneventherelastweek,theGermanpharmaceuticalfirmBoehr

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Colorectal cancer study finds potential in overlooked immune cell

          Stainingrevealsdifferentimmunecellsinahealthyhumancolon.CourtesyOliviaNewton-JohnCancerResearchinsti